These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28511884)

  • 1. The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.
    Lawson KA; Saarela O; Abouassaly R; Kim SP; Breau RH; Finelli A
    Eur Urol; 2017 Sep; 72(3):379-386. PubMed ID: 28511884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
    Khanna A; Saarela O; Lawson K; Finelli A; Haber GP; Lee B; Abouassaly R
    J Urol; 2019 Sep; 202(3):490-497. PubMed ID: 31009290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care.
    Lawson KA; Daignault K; Abouassaly R; Khanna A; Martin L; Goldenberg M; Hamilton RJ; Loblaw A; Warde P; Saarela O; Finelli A
    Eur Urol Oncol; 2021 Jun; 4(3):494-497. PubMed ID: 32938571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer.
    Kim SP; Leibovich BC; Shah ND; Weight CJ; Borah BJ; Han LC; Boorjian SA; Thompson RH
    BJU Int; 2013 Apr; 111(4):580-8. PubMed ID: 22564425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital volume and outcomes of robot-assisted partial nephrectomy.
    Xia L; Pulido JE; Chelluri RR; Strother MC; Taylor BL; Raman JD; Guzzo TJ
    BJU Int; 2018 Jun; 121(6):900-907. PubMed ID: 29232025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-Level Factors Associated with Anesthesia-Related Adverse Events in Cesarean Deliveries, New York State, 2009-2011.
    Guglielminotti J; Deneux-Tharaux C; Wong CA; Li G
    Anesth Analg; 2016 Jun; 122(6):1947-56. PubMed ID: 27195637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?
    Dagenais J; Bertolo R; Garisto J; Maurice MJ; Mouracade P; Kara O; Chavali J; Li J; Nelson R; Fergany A; Abouassaly R; Kaouk JH
    Eur Urol; 2019 Apr; 75(4):628-634. PubMed ID: 30396636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
    Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
    Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals.
    Thompson MP; Zhao X; Bekelis K; Gottlieb DJ; Fonarow GC; Schulte PJ; Xian Y; Lytle BL; Schwamm LH; Smith EE; Reeves MJ
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.